Alexander Cumbo

CIK 1685994 · President and CEO · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.86M

Companies

6

Total Filings

38

Lifetime Open-Market Net

-$13.38M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Climb Bio, Inc. (ELYM) Delisted Director $5.11 $0 3 2026-06-08
SLDB President and CEO 235,405 $7.14 $1.68M -$1.12M 12 2026-04-21
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 5 2025-07-28
VOR Director $14.36 $0 1 2025-07-18
Ra Pharmaceuticals, Inc. (RARX) Delisted Director $0 3 2020-04-03
SRPT EVP, Chief Commercial Officer 12,008 $15.31 $183.8K -$12.25M 14 2020-02-28

Recent Filings · Page 4 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-07-11 SRPT Mixed -$4.17M EDGAR
2018-05-24 SRPT Mixed +3,441 -$128.0K EDGAR
2018-03-16 SRPT Mixed +1,867 $187 EDGAR
2018-03-07 SRPT Grant (A) $0 EDGAR
2017-08-07 SRPT Mixed +6,583 -$120.0K EDGAR
2017-07-21 SRPT Mixed −3,418 -$208.4K EDGAR
2017-06-08 SRPT Grant (A) $0 EDGAR
2017-03-14 SRPT Grant (A) $0 EDGAR
Showing 3138 of 38
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.